2025-524080-20-00招募中1 期
A clinical trial to learn about the effects of INR731 alone or with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 5
- 试验地点
- 6
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Novartis Pharma Arzneimittel GmbH
Scientific
Novartis Pharma AG
研究点 (6)
Loading locations...
相似试验
招募中
1 期
A phase 1b trial to study the safety and effect of ZP9830 in patients with plaque psoriasisPlaque Psoriasis2026-525220-15-00Zealand Pharma A/S32
招募中
不适用
A Phase I/II exploratory clinical trial to evaluate the efficacy and safety of RBBM-S1 in patients requiring lumbar interbody fusion for degenerative lumbar disease, in comparison with the standard treatment of autologous bone grafting.lumbar stenosis, spondylolisthesis, spondylolysis, scoliosis, instability, disc diseasejRCT203125056936
已完成
1 期
A clinical trial in healthy people to look at how the body processes RO7268489 over time and when taken before or after a meal2023-503528-25-00F. Hoffmann-La Roche AG, F. Hoffmann-La Roche AG36
招募中
不适用
A Physician-Initiated Phase II Clinical Trial of RE-01 (Ex Vivo Cultured Peripheral Blood Mononuclear Cells) for Therapeutic Angiogenesis in Non-Healing Lower Extremity Ulcers (PHOENIX-RE Trial)non-healing lower extremity ulcersjRCT203326007610
招募中
1 期
A Multicentre, Randomised Phase Ib Trial to evaluate Neoadjuvant Immunotherapy Combination of Nivolumab alone or plus Ipilimumab with the IL-2 Superkine MDNA11 alone or with Tocilizumab in Patients with High-Risk, Surgically Resectable Melanoma – NEO-CYT2024-519010-31-00Fondazione Melanoma Onlus80